Literature DB >> 20647858

Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006.

Mitra Ebrahimi1, Mohammad A Mansournia, Ali A Haghdoost, Arash Abazari, Farshid Alaeddini, Ali Mirzazadeh, Masud Yunesian.   

Abstract

OBJECTIVE: Assessing hypertension prevalence, treatment and control by sociodemographic factors in Iran.
METHODS: We analyzed data from the 2006 National Surveillance of Risk Factors for Noncommunicable Diseases of Iran with a population-based sample of almost 30,000 people aged 15-64 years. Multiple logistic regression models were used to explore differences in hypertension prevalence, treatment and control, adjusting for sociodemographic factors, comorbidities and behavioral factors.
RESULTS: Hypertension prevalence was 17.37%. Among hypertensive patients, 33.35% were under treatment, and, among treated people, 35.10% had hypertension controlled. In multiple-regression analysis, age, male sex, low level of education, Kurd ethnicity, overweight and obesity, diabetes mellitus, lower level of physical activity and high-Human Development Index provinces were independently associated with higher prevalence of hypertension. Income and living in rural or urban area were not related to hypertension prevalence. Treatment rates were lower in men, younger people and people of low education and low income, but there were no treatment rate disparities connected to living area, ethnicity and provinces (by Human Development Index). In addition, diabetic patients, obese people and past daily smokers had higher treatment rates. Lower control rates were independently associated with male sex, higher age and lower education, but not with other variables.
CONCLUSION: In Iran, there is comparatively higher prevalence of hypertension among people of Kurdish ethnicity, people of low education and in high-Human Development Index provinces; a lower treatment rate among men, younger people, people of low education and low income; and a lower control rate among men and people of low education. These disparities should be addressed by researchers and health policy makers.

Entities:  

Mesh:

Year:  2010        PMID: 20647858     DOI: 10.1097/HJH.0b013e32833a38f2

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  24 in total

1.  The cascade of hypertension care in Cambodia: evidence from a cross-sectional population-based survey.

Authors:  Savina Chham; Veerle Buffel; Josefien Van Olmen; Srean Chhim; Por Ir; Edwin Wouters
Journal:  BMC Health Serv Res       Date:  2022-06-29       Impact factor: 2.908

Review 2.  Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis.

Authors:  Hassan Okati-Aliabad; Alireza Ansari-Moghaddam; Shiva Kargar; Mahdi Mohammadi
Journal:  J Hum Hypertens       Date:  2022-01-15       Impact factor: 2.877

3.  Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran.

Authors:  Iraj Najafi; Fatemeh Attari; Farhad Islami; Ramin Shakeri; Fatemeh Malekzadeh; Rasool Salahi; Mina Yapan Gharavi; Mostafa Hosseini; Behrooz Broumand; Ali Nobakht Haghighi; Bagher Larijani; Reza Malekzadeh
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

4.  Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population.

Authors:  Masoud M Malekzadeh; Arash Etemadi; Farin Kamangar; Hooman Khademi; Asieh Golozar; Farhad Islami; Akram Pourshams; Hossein Poustchi; Behrouz Navabakhsh; Mohammad Naemi; Paul D Pharoah; Christian C Abnet; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Alireza Esteghamati; Reza Malekzadeh
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

5.  The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran.

Authors:  Abbas Rezaianzadeh; Fatemeh Jafari; Seyed Ebrahim Sadeghi; Salar Rahimikazerooni
Journal:  J Hum Hypertens       Date:  2020-03-17       Impact factor: 3.012

6.  Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey.

Authors:  Jinwei Wang; Luxia Zhang; Fang Wang; Lisheng Liu; Haiyan Wang
Journal:  Am J Hypertens       Date:  2014-04-03       Impact factor: 2.689

7.  Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran.

Authors:  Hamid Najafipour; Hamid Reza Nasri; Mahdi Afshari; Mansoor Moazenzadeh; Mostafa Shokoohi; Afsaneh Foroud; Koorosh Etemad; Behnam Sadeghi; Ali Mirzazadeh
Journal:  Int J Public Health       Date:  2014-09-17       Impact factor: 3.380

8.  Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making.

Authors:  Pietro Amedeo Modesti; Stefano Rapi; Mohamed Bamoshmoosh; Marzia Baldereschi; Luciano Massetti; Luigi Padeletti; Gian Franco Gensini; Dong Zhao; Dawood Al-Hidabi; Husni Al Goshae
Journal:  BMJ Open       Date:  2012-08-08       Impact factor: 2.692

9.  Comparison of two methods of teaching hypertension in under graduate medical students: "planned lecture" versus "cooperative learning".

Authors:  Zahra Sobhani; Farokhlagha Ahmadi; Mohammad Jalili; Zinat Nadia Hatmi; Orkideh Olang; Khadijeh Eslami; Seyed Mansoor Gatmiri
Journal:  Nephrourol Mon       Date:  2012-03-01

10.  Epidemiology of hypertension in Yemen: effects of urbanization and geographical area.

Authors:  Pietro Amedeo Modesti; Mohamed Bamoshmoosh; Stefano Rapi; Luciano Massetti; Dawood Al-Hidabi; Husni Al Goshae
Journal:  Hypertens Res       Date:  2013-03-14       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.